Abstract
The inflammatory bowel diseases are of unknown aetiology and many aspects of their pathogenesis remain unclear. The clinical usefulness of antimicrobial agents, microbiological and immunological studies all tend to implicate the gut microflora in the maintenance of IBD, and obligate anaerobes in particular. Bacteria may also be implicated in the development of cancer in IBD.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barr, G.D., Hudson, M.J, Priddle, J.D. and Jewell, D.P. 1986. Colonic proteases to IgA1 and sIgA in patients with ulcerative colitis — a negative study. Gut. (In press).
Dickinson, R.J., O’Connor, H.J., Pinder, I., Hamilton, I., Johnston, D. and Axon, A.T.R. 1985. Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis. Gut 26: 1380–1384.
Dobbins, W.O. III. 1984. Dysplasia and malignancy in inflammatory bowel disease. Ann. Rev. Med. 35: 33–48.
Folkersen, J., Sofeldt, S. and Svehag, S-E. 1985. Application of electroblotting techniques to studies of the intestinal antibody response to extractable fecal antigens. Scand. J. Gastroent. 20: 247–253.
Hill, M.J. 1975. Bacteria and large bowel cancer. Cancer. 36: 2387–2400.
Hill, M.J. and Hudson, M.J. 1982. Intestinal microflora in inflammatory bowel disease. In: T. Shiratori and H. Nakano (eds). Inflammatory bowel disease. University of Tokyo Press. pp3–22.
Hudson M.J., Hill, M.J., Elliot, P.R., Berghouse, L.M., Burnham, W.R. and Lennard-Jones, J.E. 1984. The microbial flora of the rectal mucosa and faeces of patients with Crohn’s disease before and during antimicrobial chemotherapy. J. Med. Microbiol. 18: 335–345.
Kirsner, J.B. and Shorter, R.G. 1982. Recent developments in inflammatory bowel disease. N. Engl. J. Med. 306: 837–848.
Krook, A., Danielsson, D., Kjellander, J and Jarnerot, G. 1981. The effect of metronidazole and sulfasalazine on the faecal flora in patients with Crohn’s disease. Scand. J. Gastroent. 16: 183–192.
Krook, A., Jarnerot, G. and Danielsson, D. 1981. Clinical effect of metronidazole and sulfasalazine on Crohn’s disease in relation to changes in the faecal flora. Scand. J. Gastroent. 16: 569–575.
Mitsuoka, T. and Benno, Y. 1984. Bacterial species of intestinal microflora of patients with inflammatory bowel disease. In.: T. Shiratori and H. Nakano (eds.). Inflammatory bowel disease. Univ. of Tokyo Press. pp35–42.
Monteiro, E., Fossey, J., Shiner, M. Drasar, B.S. and Allison, A.C. 1971. Antibacterial antibodies in rectal and colonic mucosa in ulcerative colitis. Lancet. i:249–251.
Moss, A.A., Carbone, J.V. and Kressel, H.Y. 1978. Radiologic and clinical assessment of broad spectrum antibiotic therapy in Crohn’s disease. Am. J. Roentgenol. 131: 787–790.
Okamura, N., Miyazaki, K., Chida, T., Niwayama, K., Nakaya, R., Benno, Y. and Mitsuoka, T. 1985. Serogrouping of Bacteroides vulgatus by the agglutination test. J. Clin Microbiol. 22: 56–61.
Onderdonk, A.B., Cisneros, R.L. and Bronson, R.T. 1983. Enhancement of experimental ulcerative colitis by immunization with Bacteroides vulgatus. Infect. Immun. 42:783–788.
Peach, S.L. and Tabaqchali, S. 1982. Mucosa-associated flora of the human gastrointestinal tract in health and disease. Eur. J. Chemother. Antibiotic. 2: 41–50.
Ruseler van Embden, J.G.H. and Both-Patoir, H.C. 1983. Anaerobic Gram-negative faecal flora in patients with Crohn’s disease and healthy subjects. Anton. van Leeuwen. 49: 123–132.
Thayer, W.R. and Kirsner, J.B. 1980. Enteric and extra-enteric complications of intestinal bypass and inflammatory bowel disease. Are there some clues? Gastroent. 78: 1097–1100.
Ursing, B. and Kamme, C. 1975. Metronidazole for Crohn’s disease. Lancet, i: 775–777.
Wensinck, F., Custer-van Lieshout, L.M.C., Poppelaars-Kustermans, P.A.J, and Schroder, A.M. 1981. The faecal flora of patients with Crohn’s disease. J.Hyg., Camb. 87: 1–12.
Wensinck, F. and Van der Nerwe, J.P. 1981. Serum agglutins to Eubacterium and Peptostreptococcus species in Crohn’s and other diseases. J. Hyg., Camb. 87: 13–24.
Wensinck, F. Van der Merwe, J.P. and Mayberry, J.F. 1983. An international study of agglutins to Eubacterium, Peptostreptococcus and Coprococcus species in Crohn’s disease and control subjects. Digestion. 27: 63–69.
West, B., Lendrum, R. Hill, M.J. and Walker, G. 1974. Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease. Gut. 15: 960–965.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishers, Dordrecht
About this chapter
Cite this chapter
Hudson, M.J. (1987). Anaerobes and Inflammatory Bowel Disease. In: Borriello, S.P., Hardie, J.M., Drasar, B.S., Duerden, B.I., Hudson, M.J., Lysons, R.J. (eds) Recent Advances in Anaerobic Bacteriology. New Perspectives in Clinical Microbiology, vol 12. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3293-7_7
Download citation
DOI: https://doi.org/10.1007/978-94-009-3293-7_7
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7978-5
Online ISBN: 978-94-009-3293-7
eBook Packages: Springer Book Archive